STOUGHTON, Mass., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading, diversified specialty pharmaceutical company committed to improving the lives of people ...
STOUGHTON, Mass. and GEORGE TOWN, Cayman Islands, July 29, 2024 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL) and Ironshore Therapeutics Inc. today announced a definitive agreement ...
BOSTON (AP) — A Massachusetts pharmaceutical company accused of misleading doctors about the risks of its opioid product has agreed to pay $185,000 and will stop marketing to prescribers in-person, ...
Collegium Pharmaceutical, Inc. announced significant changes to its leadership and Board of Directors, with Gino Santini stepping in as Chairman as Michael Heffernan and Gwen A. Melincoff prepare to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback